Specialties
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Classics Series™
Rewinds
Click for the Rewinds Archive
Patient Basics
Subscribe for Free
License Content
Search
Saturday, February 16, 2019
About 2 Minute Medicine®
Masthead
License Content
Advertise
RSS/Email List
Apply
Contact Us
2 Minute Medicine
Specialties
All
Cardiology
Chronic Disease
Dermatology
Emergency
Endocrinology
Gastroenterology
Imaging and Intervention
Infectious Disease
Nephrology
Neurology
Obstetrics
Oncology
Ophthalmology
Pediatrics
Preclinical
Psychiatry
Public Health
Pulmonology
Surgery
Urology
Left ventricular unloading linked to lower mortality in patients with cardiogenic…
Quick Take: US National and State-Level Prevalence of Mental Health Disorders…
Ultraprocessed food consumption linked with higher mortality
Quick Take: Arthroscopic hip surgery compared with physiotherapy and activity modification…
Classics Series™
Rewinds
2 Minute Medicine Rewind February 11, 2019
2 Minute Medicine Rewind February 4, 2019
2 Minute Medicine Rewind January 28, 2019
2 Minute Medicine Rewind January 21, 2019
2 Minute Medicine Rewind January 14, 2019
Click for the Rewinds Archive
Patient Basics
Subscribe for Free
License Content
Tag: givosiran
RNA interference agent givosiran appears safe in phase I trial
James Roebker
-
February 11, 2019
0
All-time hits
The Child-Pugh score: Prognosis in chronic liver disease and cirrhosis [Classics...
July 16, 2013
The CLOT trial: Dalteparin versus warfarin [Classics Series]
December 7, 2014
Updated JNC 8 guidelines for antihypertensive drugs released
December 19, 2013
